Analysen von James Gordon
| 20.03.26 | Novartis Equal Weight | Barclays Capital | |
| 18.03.26 | GSK Underweight | Barclays Capital | |
| 12.03.26 | GSK Underweight | Barclays Capital | |
| 12.03.26 | Roche Overweight | Barclays Capital | |
| 09.03.26 | Roche Overweight | Barclays Capital | |
| 06.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 03.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 27.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
|
Werbung
|
|||
| 27.02.26 | arGEN-X Overweight | Barclays Capital | |
| 26.02.26 | GSK Underweight | Barclays Capital | |
| 26.02.26 | arGEN-X Overweight | Barclays Capital | |
| 25.02.26 | GSK Underweight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 20.02.26 | GSK Underweight | Barclays Capital | |
| 19.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 17.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 13.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 12.02.26 | Sanofi Equal Weight | Barclays Capital | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 10.02.26 | Roche Overweight | Barclays Capital | |
| 09.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 09.02.26 | Roche Overweight | Barclays Capital | |
| 03.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 27.01.26 | Roche Overweight | Barclays Capital | |
| 23.01.26 | Sanofi Equal Weight | Barclays Capital | |
| 22.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 20.01.26 | GSK Underweight | Barclays Capital | |
| 20.01.26 | Bayer Overweight | Barclays Capital | |
| 15.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 15.01.26 | GSK Underweight | Barclays Capital | |
| 15.01.26 | Novartis Equal Weight | Barclays Capital | |
| 15.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 15.01.26 | Roche Overweight | Barclays Capital | |
| 15.01.26 | Sanofi Equal Weight | Barclays Capital | |
| 07.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.01.26 | Sanofi Equal Weight | Barclays Capital | |
| 07.01.26 | GSK Underweight | Barclays Capital | |
| 07.01.26 | Novartis Equal Weight | Barclays Capital | |
| 07.01.26 | Roche Overweight | Barclays Capital | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.06.25 | GSK Underweight | JP Morgan Chase & Co. | |